EXPANDED TABLE OF CONTENTS
VOLUME 12, NUMBER 4 APRIL 2009
|
| TREATMENT HIGHLIGHTS |
| SCHIZOPHRENIA OUTCOME |
| Outcome for patients with first-episode schizophrenia may be more favorable than once thought. |
| INSOMNIA |
| Severe insomnia is found to often be persistent, with a low likelihood of spontaneous remission over a 3-year period. |
| PSYCHOTIC SYMPTOMS IN BIPOLAR MANIA |
| Psychotic symptoms are found to be common in patients with bipolar mania. |
| QUICKSTATS |
| 2009 "Sleep in America" Poll |
| FDA NEWS AND REVIEW |
| Approval (new drug): Aplenzin (bupropion hydrobromide) Extended-Release Tablets for the treatment of major depressive disorder.
|
| Approval (new indication): Symbyax (olanzapine and fluoxetine hydrochloride) Capsules for treatment-resistant depression.
|
| PSYCHOPHARMACOLOGY NOTE |
| ANTIPSYCHOTICS AND SUDDEN CARDIAC DEATH |
| Atypical antipsychotics are not found to be safer than typical antipsychotics with regard to the risk of sudden cardiac death. |
| ASSESSMENT |
| Alcohol Use Disorders Identification Test—Consumption (AUDIT-C) |
| CAGE-AID |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |
